Axar.az
UP

Axar.Az Logo

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.

Date
2019.11.23 / 21:56
Author
Axar.az
Comments
See also

Over 3.86B coronavirus vaccine shots administered worldwide

Britain abolished the masks and social distance rules

Number of people infected with coronavirus reaches 190 million

UK health minister gets COVID ahead of 'freedom day'

More dangerous variants of the corona will emerge - WHO

WHO: COVID-19 caused over 4 million deaths worldwide

Azerbaijan and Russia have signed an agreement

Pfizer-BioNTech is 70% effective against Delta variant

US allocates an additional $1M to Azerbaijan

COVAX calls on states: Vaccinated...

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla